Ardelyx Inc Revenue per Employee (ARDX), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Ardelyx inc   (NASDAQ: ARDX)
 

Ardelyx Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 23.77% in the second quarter 2026, year on year to cumulative value of $451 million, Ardelyx Inc 's revenue per employee grew on a trailing twelve months basis to $ 922,074. The productivity of Ardelyx Inc 's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 91 other companies have achieved higher revenue per employee. While Ardelyx Inc 's total ranking has deteriorated compared to the previous quarter from 409 to 991. Ardelyx Inc has 489 employees.


What is Sales per Employee Ratio?







ARDX Revenue per Employee (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Revenue Change 23.77 % 27.47 % 7.82 % 12.3 % 33.38 %
Sales per Employee (TTM) $ 922,074 874,599 832,965 814,384 789,665
ARDX's Total Ranking # 991 # 409 # 115 # 138 # 57
Seq. Revenue Change 27.95 % -24.55 % 13.49 % 12.97 % 31.77 %


Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 66
Healthcare Sector # 92
Overall Market # 991

Revenue per Employee Statistics
High Average Low
$ 874,599 $ 253,961 $ 5,331
(Mar 31 2026)   (Dec 31 2018)



Financial Statements
Ardelyx Inc 's Revenue MRQ $ 121 Millions Visit ARDX's Income Statement
Ardelyx Inc 's Revenues TTM $ 451 Millions Visit ARDX's aggregate revenue growth
What are ARDX's Sales? Visit ARDX's Sales by Segment




Other Ratios
Ardelyx Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
ARDX's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for ARDX's Competitors
Revenue per Employee for ARDX's Suppliers
Revenue per Employee for ARDX's Customers

You may also want to know
ARDX's Sales Growth Rates ARDX's Pe Price to earnings ratio ARDX's Receivables Turnover Ratio ARDX's Stock Quote
ARDX's Net Income Growth Rates ARDX's Ps Price to Sales ratio ARDX's Sales per Employee ARDX's Asset Turnover Ratio
ARDX's Net Margin ARDX's Pb Price to Book ratio ARDX's Financial Strength Ratios ARDX's Dividend Payout Ratio
Date modified: 2026-09-06T18:35:09+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Rigel Pharmaceuticals Inc  1,590,718.39 $ 276.785  Million 174 
Progyny Inc   1,531,890.19 $ 1,311.298  Million 856 
Cue Biopharma Inc   1,298,413.79 $ 37.654  Million 29 
Arvinas Inc   1,287,398.37 $ 316.700  Million 246 
Travere Therapeutics Inc   1,189,798.79 $ 591.330  Million 497 
Heron Therapeutics Inc   1,183,648.44 $ 151.507  Million 128 
Journey Medical Corp  1,175,534.48 $ 68.181  Million 58 
Theravance Biopharma inc   1,159,011.11 $ 104.311  Million 90 
Corcept Therapeutics Inc  1,138,100.00 $ 830.813  Million 730 
Biomarin Pharmaceutical Inc  1,057,626.20 $ 3,406.614  Million 3,221 
Hims and Hers Health Inc   1,055,894.35 $ 2,578.494  Million 2,442 
Assembly Biosciences Inc   1,025,273.97 $ 74.845  Million 73 
Sanara Medtech Inc   1,019,592.91 $ 110.116  Million 108 
Ani Pharmaceuticals Inc  1,008,638.14 $ 978.379  Million 970 
Coya Therapeutics Inc   1,002,393.13 $ 8.019  Million
Meiragtx Holdings Plc  986,354.84 $ 397.501  Million 403 
Arrowhead Pharmaceuticals Inc   941,624.47 $ 669.495  Million 711 
Scilex Holding Company  929,647.06 $ 31.608  Million 34 
The Oncology Institute Inc   916,137.29 $ 587.244  Million 641 
Pacira Biosciences inc   900,077.20 $ 746.164  Million 829 
Fortress Biotech Inc   897,217.95 $ 69.983  Million 78 
Alphatec Holdings Inc   892,420.59 $ 814.780  Million 913 
Merck and Co Inc   887,586.67 $ 66,569.000  Million 75,000 
Nektar Therapeutics  866,492.06 $ 54.589  Million 63 
Bridgebio Pharma Inc   849,903.46 $ 713.069  Million 839 
Pfizer Inc  849,280.00 $ 63,696.000  Million 75,000 
Syndax Pharmaceuticals Inc   845,651.01 $ 252.004  Million 298 
Xilio Therapeutics Inc   843,315.79 $ 64.092  Million 76 
Axsome Therapeutics Inc   839,534.05 $ 776.569  Million 925 
Ionis Pharmaceuticals Inc   834,107.70 $ 1,169.419  Million 1,402 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.